NYSE:CHE Chemed (CHE) Earnings Date, Estimates & Call Transcripts $514.30 +1.48 (+0.29%) (As of 08/11/2023 08:48 PM ET) Add Compare Share Share Today's Range$511.73▼$516.8650-Day Range$511.59▼$568.6152-Week Range$430.16▼$574.66Volume40,500 shsAverage Volume71,856 shsMarket Capitalization$7.76 billionP/E Ratio34.29Dividend Yield0.30%Price Target$593.00 EarningsProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateOct. 30EstimatedActual EPS (Jul. 26) $4.71 Missed By -$0.38 Consensus EPS (Jul. 26) $5.09 Read Call TranscriptListen to Call Get Chemed Earnings AlertsEnter your email address below to receive the latest news and earnings results for CHE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCHE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CHE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Chemed Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20232$4.76$5.03$4.90 Q2 20232$5.05$5.07$5.06 Q3 20232$4.93$5.01$4.97 Q4 20232$5.52$5.55$5.54 FY 20238$20.26$20.66$20.46 Q1 20242$5.26$5.27$5.27 Q2 20242$5.59$5.67$5.63 Q3 20242$5.59$5.62$5.61 Q4 20242$5.85$6.07$5.96 FY 20248$22.29$22.63$22.46 Q1 20251$5.91$5.91$5.91 Q2 20251$6.14$6.14$6.14 CHE Earnings Date and InformationChemed last announced its earnings results on July 26th, 2023. The reported $4.71 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.09 by $0.38. The company had revenue of $553.80 million for the quarter, compared to analysts' expectations of $562.54 million. Its revenue for the quarter was up 4.2% on a year-over-year basis. Chemed has generated $15.00 earnings per share over the last year ($15.00 diluted earnings per share) and currently has a price-to-earnings ratio of 34.3. Earnings for Chemed are expected to grow by 16.61% in the coming year, from $19.14 to $22.32 per share. Chemed has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 30th, 2023 based off prior year's report dates.Read More Chemed Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 10/30/2023Estimated)------- 7/26/2023Q2 2023$5.09$4.71($0.38)$5.91$562.54 million$553.80 million 4/26/2023Q1 2023$4.38$4.39+$0.01$5.20$546.18 million$560.16 million2/24/2023Q4 2022$5.30$5.39+$0.09$6.65$546.60 million$546.65 million 10/31/2022Q3 2022$4.61$4.74+$0.13$5.70$527.05 million$526.47 million 7/27/2022Q2 2022$4.78$4.84+$0.06$5.28$538.07 million$531.29 million 4/26/2022Q1 2022$4.49$4.79+$0.30$5.36$537.08 million$530.55 million Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2/24/2022Q4 2021$5.06$5.25+$0.19$5.69$543.18 million$541.00 million 10/28/2021Q3 2021$4.49$5.06+$0.57$5.57$531.87 million$538.67 million 7/26/2021Q2 2021$4.29$4.60+$0.31$5.69$511.85 million$532.26 million 4/27/2021Q1 2021$4.20$4.44+$0.24$4.87$516.96 million$527.36 million 2/22/2021Q4 2020$5.13$5.13-$3.30$537.20 million$533.00 million 10/29/2020Q3 2020$3.97$4.86+$0.89$5.58$514.22 million$528.30 million Chemed Earnings - Frequently Asked Questions When is Chemed's earnings date? Chemed has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 30th, 2023 based off last year's report dates. Learn more on CHE's earnings history. Did Chemed beat their earnings estimates last quarter? In the previous quarter, Chemed (NYSE:CHE) missed the analysts' consensus estimate of $5.09 by $0.38 with a reported earnings per share (EPS) of $4.71. Learn more on analysts' earnings estimate vs. CHE's actual earnings. How can I listen to Chemed's earnings conference call? The conference call for Chemed's latest earnings report can be listened to online. Listen to Conference Call How can I read Chemed's conference call transcript? The conference call transcript for Chemed's latest earnings report can be read online. Read Transcript How much revenue does Chemed generate each year? Chemed (NYSE:CHE) has a recorded annual revenue of $2.13 billion. How much profit does Chemed generate each year? Chemed (NYSE:CHE) has a recorded net income of $249.62 million. CHE has generated $15.00 earnings per share over the last four quarters. What is Chemed's price-to-earnings ratio? Chemed (NYSE:CHE) has a trailing price-to-earnings ratio of 34.29 and a forward price-to-earnings ratio of 26.87. The price/earnings-to-growth ratio is 3.04. What is Chemed's EPS forecast for next year? Chemed's earnings are expected to grow from $19.14 per share to $22.32 per share in the next year, which is a 16.61% increase. More Earnings Resources from MarketBeat Related Companies: AMED Earnings Results OPCH Earnings Results SWAV Earnings Results MEDP Earnings Results THC Earnings Results AGL Earnings Results INSP Earnings Results EHC Earnings Results XRAY Earnings Results ACHC Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Alibaba Explodes On Earnings, Inching Toward Triple Digit Prices2 Stocks that Doubled Earnings Estimates and Sold Off More Good News Coming? GoodRx Spikes Ahead of Q2 EarningsIs Growth Priced into Amgen Stock after Earnings Beat?PayPal Stock Falls On Earnings Beat, Time For A Dip Buy?Extreme Networks Leaps 8% As Q4 Earnings More Than DoubleWhat Generac’s Earnings May Say About the Strength of the Economy This page (NYSE:CHE) was last updated on 8/14/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.